4D-Printed Model Reveals Why Triple-Negative Breast Cancer Resists Treatment

Scientists at the Indian Institute of Science have built a laboratory model that folds itself into the shape of a breast duct—the very place where some cancers begin. The model is made from a material that starts as a flat sheet but curls into a tiny tube when placed in liquid, all triggered by visible light. Inside these tubes, researchers placed triple-negative breast cancer cells and watched what happened.

Triple-negative breast cancer is one of the most aggressive forms of the disease, and it has long resisted treatment in ways that remain poorly understood. The problem, in part, is that cancer cells do not live as a simple flat layer in the human body. They exist within a three-dimensional world of tissue with a particular shape, physical stiffness, and the constant movement of fluid flowing around them. Most laboratory studies flatten this reality into a two-dimensional petri dish, losing the texture of the actual tumor environment.

Kaushik Chatterjee and his team designed their material to capture what a real breast duct looks like and how it behaves. "The printed material initially forms a flat sheet but then folds itself into a small tube when placed in liquid," Chatterjee explained. The light-activated printing process allows precise control over the structure before it self-assembles. Once the tubes were ready, the researchers introduced cancer cells and ran two parallel experiments: one in which the tubes sat still, and another in which they were gently rocked to mimic the flow of fluid through living tissue.

What they found was striking. The cancer cells thrived in both conditions, but their behavior diverged sharply when movement entered the picture. Cells grown under dynamic conditions—those experiencing fluid flow—showed higher metabolic activity, altered their shape and organization, and most importantly, survived chemotherapy treatment at higher rates. When exposed to doxorubicin, a standard chemotherapy drug, the cells under flow conditions proved more resistant than their stationary counterparts. This observation offers a window into why some triple-negative breast cancers fail to respond to drugs that should kill them.

Sriram Bharath Gugulothu, the study's co-author, emphasized that the model allows researchers to examine multiple influences simultaneously rather than testing them in isolation. "Cancer cells behavior can vary highly due to dynamic culture compared to static culture conditions," he noted. The ability to study tissue shape, stiffness, and fluid movement together in one system represents a meaningful shift in how researchers can approach the problem.

The work, published in Engineered Regeneration in July 2026, does not yet offer a treatment for patients or replace clinical testing. But it creates a bridge between the oversimplified petri dish and the complexity of the human tumor. Researchers can now evaluate potential therapies in a model that more closely mirrors what actually happens inside the body. The Indian Institute of Science team received funding from the Anusandhan National Research Foundation, part of the Indian government's commitment to advancing cancer research.

For oncologists and drug developers, this model opens a new avenue for understanding why certain cancers evade treatment and for testing whether new therapies might overcome that resistance. The next step is to move from the laboratory tube to the clinic—to see whether insights gained from this folded structure can translate into better outcomes for patients facing one of breast cancer's most difficult forms.